Priovant Therapeutics, Inc.

This study is testing whether an oral medication called brepocitinib is safe and effective for controlling active uveitis, a type of serious eye inflammation that can lead to vision loss. It will involve about 371 adults with intermediate, posterior, or panuveitis. Participants w…

This study is testing whether an oral medication called brepocitinib can help adults with dermatomyositis, an autoimmune disease that causes muscle weakness and skin rashes. About 241 participants will receive either the active drug or a placebo pill for 52 weeks to see which gro…